Author:
Wartak Andreas,Garber John G.,Yuan Qian,Shreffler Wayne G.,Hesterberg Paul E.,Katz Aubrey J.,Osman Hany,Leung Hui Min,Gao Anna,Otuya David O.,Grant Catriona,Gardecki Joseph A.,Nishioka Norman,Tearney Guillermo J.,Apiou-Sbirlea Gabriela
Abstract
AbstractHistopathologic analysis of biopsy specimens obtained via white light endoscopy (WLE) is the gold standard for the diagnosis of several mucosal diseases in the upper gastrointestinal (GI) tract. However, this standard of care entails a series of critical shortcomings such as missing depth information, high costs, time inefficiency, low-resolution imaging in vivo, high sampling variability, missing intrinsic tissue-specific contrast, and anesthesia related risk. In the quest for a diagnostic technology to replace the current standard of care, in vivo optical endomicroscopy has emerged as a promising alternative. This paper tells the story of a cluster of optical microscopy-based modalities invented, further developed, or first-validated in the laboratory of Dr. Guillermo J. Tearney (Tearney Lab) at the Wellman Center for Photomedicine of Massachusetts General Hospital over the past two decades, that combined lead to a novel method for diagnosis of eosinophilic esophagitis (EoE). Rather than being a comprehensive literature review, this paper aims to describe the translational journey towards a disease specific diagnostic and research tool for this increasingly recognized yet poorly understood immune-mediated disorder of the esophagus.
Funder
National Institutes of Health
NinePoint Medical
CN USA Biotech Holdings
John and Dottie Remondi Foundation
Hazard Family Foundation
American Partnership for Eosinophilic Disorders
Publisher
Springer Science and Business Media LLC
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献